ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1220 • 2012 ACR/ARHP Annual Meeting

    Occurrence and Morbidity of Lower Extremity Ulcer in Rheumatoid Arthritis – A Population Based Study

    Adlene Jebakumar1, Cynthia S. Crowson2, Prabhu D. Udayakumar1, Sherine E. Gabriel3 and Eric L. Matteson1, 1Rheumatology, Mayo Clinic, Rochester, MN, 2Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 3Health Sciences Research & Div of Rheumatology, Mayo Clinic, Rochester, MN

    Background/Purpose: Lower extremity (LE) ulcer is a known complication of rheumatoid arthritis (RA). However, little is known regarding the magnitude and morbidity associated with this…
  • Abstract Number: 1221 • 2012 ACR/ARHP Annual Meeting

    Low Muscle Density in Rheumatoid Arthritis and Modified Association with Total Fat Mass, Results of a Pilot Study

    Joshua Baker1, Joan Marie Von Feldt2 and Mary Beth Leonard3, 1Medicine/Rheumatology, University of Pennsylvania, Philadelphia, PA, 2Rheumatology, Univ of Pennsylvania/Philadelphia VAMC, Philadelphia, PA, 3Pediatrics, The Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Fatty infiltration of muscle (myosteatosis) results in a decrease in muscle density. Prior studies documented that skeletal muscle attenuation determined by CT was associated…
  • Abstract Number: 1222 • 2012 ACR/ARHP Annual Meeting

    Incidence and Time Trends of Malignancy in Rheumatoid Arthritis: A Population Based Study 1980-2007

    Kerry Wright1, Cynthia S. Crowson2, Sherine E. Gabriel3 and Eric L. Matteson1, 1Rheumatology, Mayo Clinic, Rochester, MN, 2Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 3Health Sciences Research & Div of Rheumatology, Mayo Clinic, Rochester, MN

    Background/Purpose: to determine the incidence and time trends of malignancy in patients with rheumatoid arthritis (RA) in 1980-2007 compared to individuals without RA from the…
  • Abstract Number: 1223 • 2012 ACR/ARHP Annual Meeting

    Frequency of Deep Vein Thromboses and Pulmonary Emboli in Rheumatoid Arthritis

    Christian A. Pineau1, Evelyne Vinet2 and Sasha Bernatsky3, 1Rheumatology, McGill University Health Center, Montreal, QC, Canada, 2McGill University Health Center, Montreal, QC, Canada, 3Clinical Epidemiology, Research Institute of the McGill University Health Ctre, Montreal, QC, Canada

    Background/Purpose: There are few data regarding the frequency of deep vein thromboses (DVTs) and pulmonary emboli (PE’s) in patients with rheumatoid arthritis (RA). To determine…
  • Abstract Number: 1224 • 2012 ACR/ARHP Annual Meeting

    Rheumatoid Arthritis Disease Activity During Pregnancy Affects the Postnatal Catch-up Growth of the Child

    Florentien D.O. de Steenwinkel1, Anita C.S. Hokken-Koelega2, Maria A.J. de Ridder3, Johanna M.W. Hazes4 and Radboud J.E.M. Dolhain1, 1Rheumatology, Erasmus Medical Center, Rotterdam, Netherlands, 2Pediatrics, Subdivision of Endocrinology, Erasmus Medical Center- Sophia Children's Hospital, Rotterdam, Netherlands, 3Bio Statistics, Erasmus Medical Center, Rotterdam, Netherlands, 4Rheumatology, Erasmus MC, Rotterdam, Netherlands

    Background/Purpose:  Active rheumatoid arthritis (RA) during pregnancy is associated with lower birth weight. Active RA during pregnancy can be treated with prednisone. However, studies have…
  • Abstract Number: 1225 • 2012 ACR/ARHP Annual Meeting

    Self Reported Comorbidity Is Common in Early Inflammatory Arthritis and Associated with Poorer Function and Quality of Life and Greater Disease Activity: Results From the Canadian Early Arthritis Cohort

    Carol A. Hitchon1, Gilles Boire2, Boulos Haraoui3, Edward Keystone4, Janet E. Pope5, Vivian P. Bykerk6 and Canadian Early Arthritis Cohort (CATCH) Investigators7, 1University of Manitoba, Winnipeg, MB, Canada, 2Rheumatology Division, Centre Hospitalier Universitaire de Sherbrooke, Université de Sherbrooke, Sherbrooke, QC, Canada, 3Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Montreal, QC, Canada, 4University of Toronto, Toronto, ON, Canada, 5Medicine/Rheumatology, St. Joseph Health Care London, University of Western Ontario, London, ON, Canada, 6Rheumatology, Hospital for Special Surgery, New York, NY, 7Toronto, Canada

    Background/Purpose: Chronic comorbid medical conditions may contribute to poor outcomes in rheumatoid arthritis.  The extent of comorbidity, in particular cardiovascular disease (CVD), may  be related…
  • Abstract Number: 1226 • 2012 ACR/ARHP Annual Meeting

    Transition Time to Osteoporosis in Patients with Rheumatoid Arthritis

    Jiwon Hwang1, Joong Kyong Ahn2, Ji Young Chai3, Hoon-Suk Cha1, Jaejoon Lee1 and Eunmi Koh1, 1Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, 2Department of Medicine, Kangbuk Samsung hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea, 3Division of Rheumatology, Jesang Hospital, Seongnam-si Gyeonggi-do, South Korea

    Background/Purpose: Rheumatoid arthritis (RA) is an independent risk factor for osteoporosis. Although bone mineral density (BMD) testing is routinely performed in patients with RA, the…
  • Abstract Number: 1227 • 2012 ACR/ARHP Annual Meeting

    Rheumatoid Arthritis-Associated Interstitial LUNG Disease: Clinical Spectrum of A Large Cohort From A Respiratory Referral Center

    Joshua J. Solomon1, Gloria M. Russell2, Jill B. Ketzer3, Amy L. Olson3, Evans R. Fernandez-Perez3, Tristan J. Huie3, Jeffrey J. Swigris3, Kevin K. Brown4 and Aryeh Fischer5, 1Autoimmune Lung Center, Denver, 2Pontificia Universidad Católica Madre y Maestra, Santiago, Dominican Republic, 3Autoimmune Lung Center, National Jewish Health, Denver, CO, 4Autoimmune Lung Center, National Jewish Hospital, Denver, CO, 5Rheumatology / ILD Program, National Jewish Health, Denver, CO

    Background/Purpose: Rheumatoid arthritis (RA) has a myriad of pulmonary manifestations and RA-associated interstitial lung disease (RA-ILD) causes the most clinical concern. Subclinical ILD may be…
  • Abstract Number: 1228 • 2012 ACR/ARHP Annual Meeting

    Contributions of Inflammation, Inactivity, and Low Dose Prednisone Use to Skeletal Muscle Insulin Resistance in Well-Controlled Rheumatoid Arthritis

    Hiba Abouassi, Lori Bateman, Gary E. McDaniel, Lorraine Elliott-Penry, Michael Muehlbauer, E. William St. Clair, William E. Kraus and Kim M. Huffman, Medicine, Duke University Medical Center, Durham, NC

    Background/Purpose: Rheumatoid arthritis (RA) is associated with a high prevalence of insulin resistance.   Most prior investigations of insulin resistance in RA have examined fasting glucose…
  • Abstract Number: 1229 • 2012 ACR/ARHP Annual Meeting

    Rheumatoid Arthritis and Risks of Malignant Lymphoma – Are Risks Still Increased?

    Karin Hellgren1, Eva Baecklund2, Karin E Smedby3, Carin Backlin4, Christer Sundstrom5 and Johan Askling6, 1Department of Medicine , Karolinska Insitutet at Karolinska University Hospital, Unit of Rheumatology, Stockholm, Sweden, 2Department of Medical Sciences, Rheumatology, Uppsala University Hospital, Uppsala, Sweden, 3Department of Medicine Karolinska Institutet at Karolinska University Hospital, Clinical Epidemiology Unit, Stockholm, Sweden, 4Uppsala University, Department of Medical Sciences,, Uppsala, Sweden, 5Uppsala University, Department of Genetics and Pathology, Uppsala, Sweden, 6Rheumatology Unit, Karolinska University Hospital, Stockholm, Sweden

    Background/Purpose: Patients with established Rheumatoid Arthritis (RA) are at increased risk of malignant lymphomas. We have previously demonstrated a strong association between inflammatory intensity and…
  • Abstract Number: 1230 • 2012 ACR/ARHP Annual Meeting

    The Role of Sleep Problems in Conditioned Pain Modulation in Rheumatoid Arthritis

    Yvonne C. Lee1, Bing Lu2, Robert R. Edwards3, Ajay Wasan4, Nicholas Nassikas5, Daniel J. Clauw6, Daniel H. Solomon7 and Elizabeth W. Karlson8, 1Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 2Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 3Anesthesiology, Brigham & Womens Hospital, Chestnut Hill, MA, 4Anesthesiology, Brigham and Women's Hospital, Chestnut Hill, MA, 5Rheumatology, Brigham and Women's Hospital, Boston, MA, 6Anesthesiology/Internal Medicine (Rheum), University of Michigan, Ann Arbor, MI, 7Division of Rheumatology, Brigham and Women's Hospital, Boston, MA, 8Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

    Background/Purpose:   Among rheumatoid arthritis (RA) patients, pain may exist out of proportion to peripheral inflammation.  This observation suggests that central nervous system pain amplification…
  • Abstract Number: 1231 • 2012 ACR/ARHP Annual Meeting

    Rheumatoid Arthritis Is Associated with Likelihood of Being Overweight in Women

    Irum-Mona Idrees1, H. Lester Kirchner2 and Androniki Bili1, 1Rheumatology, Geisinger Medical Center, Danville, PA, 2Geisinger Center for Health Research, Geisinger Health System, Danville, PA

    Background/Purpose: Adipose tissue is metabolically active producing adipokines, which, along with locally attracted cytokines, are active participants in inflammation and its regulation. Since RA a…
  • Abstract Number: 1232 • 2012 ACR/ARHP Annual Meeting

    Association of Actometer Assessed Physical Activity and Fatigue in Patients with Rheumatoid Arthritis: Patients with a Lower Daily Activity Have More Fatigue

    Sanne van Dartel1, Han Repping-Wuts1, Dewy van Hoogmoed1, Hans Knoop2, Gijs Bleijenberg1, Piet L.C. van Riel3 and J. Fransen3, 1Reumatology 470, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 2Nijmegen Expert Centre of Chronic Fatigue, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 3Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands

    Background/Purpose: Fatigue in rheumatoid arthritis (RA) is related to pain and disability, and several psycho-social factors such as coping strategies. In Chronic Fatigue Syndrome (CFS),…
  • Abstract Number: 1233 • 2012 ACR/ARHP Annual Meeting

    Effect of Insoles On the Rheumatoid Foot

    Emilia Moreira1, Anamaria Jones2, Hilda A. Oliveira3, Fabio Jennings1, Artur R.C. Fernandes4 and Jamil Natour5, 1Rheumatology Division, Universidade Federal de Sao Paulo, Sao Paulo, Brazil, 2Unifesp-EPM, Universidade Federal de Sao Paulo, Sao Paulo, Brazil, 3Rheumatology, Universidade Federal de Sao Paulo, Sao Paulo, Brazil, 4Radiology Division, Universidade Federal de São Paulo, Sao Paulo, Brazil, 5Rheumatology Division, Universidade Federal de São Paulo, São Paulo, Brazil

    Background/Purpose: Rheumatoid arthritis (RA) is a systemic inflammatory disease characterized by peripheral polyarthritis, which may cause joint destruction and deformities, resulting in reduced function and…
  • Abstract Number: 1234 • 2012 ACR/ARHP Annual Meeting

    Barriers, Benefits and Preferences for Exercise in RA Patients: A Cross Sectional Study

    Yves Henchoz1, Pascal Zufferey2 and Alexander So3, 1Département de chiropratique, Université du Québec à Trois-Rivières, Trois-Rivières, QC, Canada, 2Service of Rheumatology, Department of Musculoskeletal Medicine, Lausanne University Hospital, Lausanne, Switzerland, 3Rheumatology, CHUV, Univ of Lausanne, Lausanne, Switzerland

    Background/Purpose: Physical exercise is safe and effective as an adjunctive nonpharmacological treatment modality in the management of rheumatoid arthritis (RA). It is well established that…
  • « Previous Page
  • 1
  • …
  • 2338
  • 2339
  • 2340
  • 2341
  • 2342
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology